These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 35900248)
1. The role of macrophage TAM receptor family in the acute-to-chronic progression of liver disease: From friend to foe? Huang H; Jiang J; Chen R; Lin Y; Chen H; Ling Q Liver Int; 2022 Dec; 42(12):2620-2631. PubMed ID: 35900248 [TBL] [Abstract][Full Text] [Related]
2. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Myers KV; Amend SR; Pienta KJ Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471 [TBL] [Abstract][Full Text] [Related]
3. GAS6/TAM Axis as Therapeutic Target in Liver Diseases. Tutusaus A; Morales A; García de Frutos P; Marí M Semin Liver Dis; 2024 Feb; 44(1):99-114. PubMed ID: 38395061 [TBL] [Abstract][Full Text] [Related]
4. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice. Han J; Bae J; Choi CY; Choi SP; Kang HS; Jo EK; Park J; Lee YS; Moon HS; Park CG; Lee MS; Chun T Autophagy; 2016 Dec; 12(12):2326-2343. PubMed ID: 27780404 [TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function. Lee CH; Chun T Mol Cells; 2019 Jan; 42(1):1-7. PubMed ID: 30699285 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis. Yu W; Wang S; Wang Y; Chen H; Nie H; Liu L; Zou X; Gong Q; Zheng B Front Immunol; 2023; 14():1147710. PubMed ID: 37138859 [TBL] [Abstract][Full Text] [Related]
7. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560 [TBL] [Abstract][Full Text] [Related]
8. The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation. Grabiec AM; Hussell T Semin Immunopathol; 2016 Jul; 38(4):409-23. PubMed ID: 26957481 [TBL] [Abstract][Full Text] [Related]
9. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation. Nishi C; Yanagihashi Y; Segawa K; Nagata S J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565 [TBL] [Abstract][Full Text] [Related]
10. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC Dis Markers; 2019; 2019():2304931. PubMed ID: 31583026 [TBL] [Abstract][Full Text] [Related]
11. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment. Zhou L; Matsushima GK Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493 [TBL] [Abstract][Full Text] [Related]
12. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells. Al Kafri N; Hafizi S Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510 [TBL] [Abstract][Full Text] [Related]
13. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Bellan M; Cittone MG; Tonello S; Rigamonti C; Castello LM; Gavelli F; Pirisi M; Sainaghi PP Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614787 [TBL] [Abstract][Full Text] [Related]
14. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction. DeBerge M; Glinton K; Subramanian M; Wilsbacher LD; Rothlin CV; Tabas I; Thorp EB J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33529176 [TBL] [Abstract][Full Text] [Related]
15. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. Wang Q; Bu Q; Liu M; Zhang R; Gu J; Li L; Zhou J; Liang Y; Su W; Liu Z; Wang M; Lian Z; Lu L; Zhou H JHEP Rep; 2022 Nov; 4(11):100555. PubMed ID: 36185574 [TBL] [Abstract][Full Text] [Related]
16. Resolving inflammation by TAM receptor activation. Vago JP; Amaral FA; van de Loo FAJ Pharmacol Ther; 2021 Nov; 227():107893. PubMed ID: 33992683 [TBL] [Abstract][Full Text] [Related]
17. TAM receptor tyrosine kinase function and the immunopathology of liver disease. Mukherjee SK; Wilhelm A; Antoniades CG Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G899-905. PubMed ID: 26867565 [TBL] [Abstract][Full Text] [Related]